|
Name |
Butyl linoleate
|
Molecular Formula | C22H40O2 | |
IUPAC Name* |
butyl (9Z,12Z)-octadeca-9,12-dienoate
|
|
SMILES |
CCCCC/C=C\C/C=C\CCCCCCCC(=O)OCCCC
|
|
InChI |
InChI=1S/C22H40O2/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-19-20-22(23)24-21-6-4-2/h9-10,12-13H,3-8,11,14-21H2,1-2H3/b10-9-,13-12-
|
|
InChIKey |
SVGGKWILBMPIJV-UTJQPWESSA-N
|
|
Synonyms |
butyl linoleate; 9,12-Octadecadienoic acid (Z,Z)-, butyl ester; M960F1ZW3F; 2634-45-9; Butyl (9Z,12Z)-octadeca-9,12-dienoate; UNII-M960F1ZW3F; EINECS 220-121-4; BUTYL LINOLATE; N-BUTYL LINOLEATE; Butyl 9,12-octadecadienoate; SCHEMBL542265; DTXSID701016821; LINOLEIC ACID, BUTYL ESTER; Q27283685; 9,12-OCTADECADIENOIC ACID (9Z,12Z)-, BUTYL ESTER
|
|
CAS | 2634-45-9 | |
PubChem CID | 6436910 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 336.6 | ALogp: | 8.2 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 18 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 24 | QED Weighted: | 0.161 |
Caco-2 Permeability: | -4.915 | MDCK Permeability: | 0.00004320 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.069 | 20% Bioavailability (F20%): | 0.998 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.214 | Plasma Protein Binding (PPB): | 98.97% |
Volume Distribution (VD): | 3.182 | Fu: | 1.03% |
CYP1A2-inhibitor: | 0.35 | CYP1A2-substrate: | 0.209 |
CYP2C19-inhibitor: | 0.45 | CYP2C19-substrate: | 0.067 |
CYP2C9-inhibitor: | 0.293 | CYP2C9-substrate: | 0.948 |
CYP2D6-inhibitor: | 0.64 | CYP2D6-substrate: | 0.817 |
CYP3A4-inhibitor: | 0.759 | CYP3A4-substrate: | 0.102 |
Clearance (CL): | 4.973 | Half-life (T1/2): | 0.9 |
hERG Blockers: | 0.546 | Human Hepatotoxicity (H-HT): | 0.095 |
Drug-inuced Liver Injury (DILI): | 0.029 | AMES Toxicity: | 0.14 |
Rat Oral Acute Toxicity: | 0.058 | Maximum Recommended Daily Dose: | 0.048 |
Skin Sensitization: | 0.967 | Carcinogencity: | 0.181 |
Eye Corrosion: | 0.556 | Eye Irritation: | 0.689 |
Respiratory Toxicity: | 0.703 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001583 | 0.833 | D0O1TC | 0.610 | ||||
ENC001714 | 0.776 | D0O1PH | 0.552 | ||||
ENC001711 | 0.776 | D0OR6A | 0.546 | ||||
ENC001605 | 0.767 | D0UE9X | 0.537 | ||||
ENC001660 | 0.767 | D00MLW | 0.417 | ||||
ENC001670 | 0.714 | D07ILQ | 0.387 | ||||
ENC001679 | 0.714 | D0G2MW | 0.380 | ||||
ENC001920 | 0.703 | D0H2YX | 0.357 | ||||
ENC001535 | 0.703 | D0Z5SM | 0.352 | ||||
ENC001584 | 0.703 | D05ATI | 0.349 |